Exclusion criteria for outpatient treatment of venous thromboembolism with rivaroxaban.
If NONE of the above, may be considered for outpatient treatment of VTE with rivaroxaban.
Not yet validated.
30 patients with PE, 71 patients with DVT, and 5 with both who met inclusion / exclusion criteria were treated with rivaroxaban and discharged from the emergency department. Monitored for a mean of 389 days, no patient had VTE recurrence or clinically relevant bleeding event.
Beam, DM et al. Immediate Discharge and Home Treatment with Rivaroxaban of Low-risk Venous Thromboembolism Diagnosed in Two U.S. Emergency Departments: a One-year Pre-planned Analysis. Acad Emerg Med.2015. 22: 789-795.